IDEXX Laboratories, Inc.
IDXX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $51,172,533 | $43,128,708 | $34,149,914 | $33,838,410 |
| - Cash | $208,166 | $164,594 | $163,970 | $288,266 |
| + Debt | $256,491 | $1,237,271 | $1,059,359 | $986,948 |
| Enterprise Value | $51,220,858 | $44,201,385 | $35,045,303 | $34,537,092 |
| Revenue | $1,105,239 | $1,109,457 | $998,427 | $954,288 |
| % Growth | -0.4% | 11.1% | 4.6% | – |
| Gross Profit | $683,354 | $694,732 | $623,379 | $570,660 |
| % Margin | 61.8% | 62.6% | 62.4% | 59.8% |
| EBITDA | $392,053 | $409,445 | $351,813 | $298,563 |
| % Margin | 35.5% | 36.9% | 35.2% | 31.3% |
| Net Income | $274,610 | $293,989 | $242,677 | $216,149 |
| % Margin | 24.8% | 26.5% | 24.3% | 22.7% |
| EPS Diluted | 3.4 | 3.63 | 2.96 | 2.62 |
| % Growth | -6.3% | 22.6% | 13% | – |
| Operating Cash Flow | $402,340 | $185,743 | $237,962 | $262,025 |
| Capital Expenditures | -$31,114 | -$34,102 | -$30,026 | -$39,255 |
| Free Cash Flow | $371,226 | $151,641 | $207,936 | $222,770 |